ViroCell Biologics and AvenCell Therapeutics Announce Retroviral Vector Manufacturing Collaboration to Accelerate Development of Novel Allogeneic CAR-T Therapies for Blood Cancers
LONDON & NEW YORK, July 29, 2025--(BUSINESS WIRE)--ViroCell Biologics ("ViroCell"), a specialist viral vector Contract Development and Manufacturing Organisation ("CDMO") for cell and gene therapy (CGT) clinical trials, announces a manufacturing collaboration with and the successful delivery of a novel retroviral vector to AvenCell Therapeutics, Inc. ("AvenCell"), a leading clinical-stage cell therapy company focused on advancing allogeneic switchable CAR-T cell therapies. This first retroviral vector will be used to manufacture AVC-203, an investigational CD19/CD20 dual-targeted cell therapy for the treatment of B cell malignancies and autoimmune diseases.
AvenCell's AV203 is its second investigational cell therapy using its differentiated allogeneic engineering to provide an "off-the-shelf" product engineered to overcome graft-versus-host disease as well as graft rejection by host T and Natural Killer ("NK") cells. AVC-203 is designed to achieve superior efficacy compared to currently-approved CAR-Ts while enabling immediate treatment and greater patient access at much lower cost and complexity. The further inclusion of AvenCell's RevCAR™ receptor in AVC203 allows for additional antigen targeting (with "off/on" capability in vivo) beyond CD19 and CD20.
AvenCell selected ViroCell as its partner to manufacture the retroviral vector for this program based on the CDMO's expertise and track record in delivering high yield vectors at speed. Incorporating a cell line acquired by AvenCell into the GMP manufacturing process, ViroCell successfully delivered a high yield vector while meeting AvenCell's accelerated timeline. This program evidences ViroCell's ability to deliver a bespoke, complex manufacturing process in the allogeneic CAR-T cell therapy space, ultimately, enabling AvenCell's timelines for clinical entry. AvenCell's AVC-203 is expected to enter a first-in-human phase I study in patients with relapsed/refractory B cell lymphoma in H2/2025.
John W. Hadden II, CEO of ViroCell, commented: "We are thrilled to partner with AvenCell and support their innovative allogeneic CAR-T therapy platform. I am proud of Team ViroCell's accomplishments on the successful end-to-end delivery of this retroviral vector and accelerating a novel therapy into clinical development in an area of high unmet need. We look forward to continuing our work with AvenCell on their exciting platform."
Andrew Schiermeier, Ph.D., CEO, AvenCell, added: "We are delighted with ViroCell's performance in process development and GMP manufacture of this complex retroviral vector. We selected ViroCell to support our platform because we knew that they could execute reliably in areas where other CDMOs can't. The delivery of this retroviral vector for AVC-203 is proof that our trust in ViroCell was well placed."
Notes to editor:
ViroCell
ViroCell Biologics is an innovation-driven Contract Development and Manufacturing Organization ("CDMO") focused exclusively on the design, de-risking, and GMP manufacture of viral vectors for clinical trials. Built around one of the most prolific academic viral vector manufacturing teams, ViroCell was created to address the global demand for precisely engineered viral vectors. The team leverages its deep track record to help clients to de-risk and accelerate novel cell and gene therapies into and through clinical development, with a mission of being the partner of choice for corporate and academic innovators. Focused initially on manufacturing lentiviral and retroviral vectors, ViroCell enables clients to start clinical trials on a scalable platform, delivering value by reducing costs, time and regulatory risk.
www.virocell.com
AvenCell Therapeutics
AvenCell derives its name from the French word "avenir" to reflect the aim to be the FUTURE of cell therapy. AvenCell is building a truly transformative cell therapy company that targets difficult-to-treat cancers, with its lead programs focusing on acute myeloid leukemia (AML) and additional programs targeting other hematological malignancies. AvenCell was formed with the goal to create truly allogeneic cells that persist as long or longer than autologous therapies and develop a universal and switchable construct that allows complete control and target redirection of T cells after they are infused into a patient. Integration of these two platforms allows for complete separation of the manufacturing of cells from ultimate patient and cancer target, thus providing significant scalability potential at orders of magnitude more efficient than current approaches.
AvenCell Therapeutics, Inc. was launched in 2021 by Blackstone Life Sciences, Cellex Cell Professionals, and Intellia Therapeutics. AvenCell is headquartered in Watertown, Massachusetts with additional R&D and manufacturing operations in Dresden, Germany.
www.avencell.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250728879540/en/
Contacts
For more information, please contact: ViroCell John W. Hadden II, CEOinfo@virocell.com
For media enquiries, please contact: ViroCell – FTI Consulting Simon Conway / Tim StamperViroCell@fticonsulting.com +44 (0)20 3727 1000
AvenCell – H Advisors Emma Prenn-Vasilakisemma.prenn-vasilakis@h-advisors.global +1 (917) 763-6685
擷取數據時發生錯誤
登入存取你的投資組合
擷取數據時發生錯誤
擷取數據時發生錯誤
擷取數據時發生錯誤
擷取數據時發生錯誤
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Consortium 'ready' to buy ailing Morecambe
London-based sports investment company Panjab Warriors have released a statement to say they are "ready, willing and able" to buy Morecambe. The Shrimps were suspended by the National League until 20 August on Monday over failing to comply with the league's rules. Panjab Warriors have been in talks with the club's owner Jason Whittingham for over a year and a deal had looked set to be concluded earlier this summer. They have now said in a joint-statement with minority shareholders, the Shrimps Trust and Lizzi Collinge MP that the National League is ready to sanction the deal and "immediately lift the suspension and embargo should it be agreed". BBC investigates takeover turmoil behind Morecambe suspension Morecambe suspended from the National League Morecambe owner 'not heard from' potential bidder As it stands, Morecambe's fixture away to Boston United on 9 August, their first home game against Brackley Town on 16 August, and the trip to Scunthorpe United on 19 August, will no longer take place as scheduled. Whittingham, who has been looking to sell the club since 2022, announced a new buyer, named as a consortium led by Jonny Cato, had been found earlier in July, but it remains unclear where that bid also stands. Whittingham said on Sunday he had "not heard from" Panjab Warriors in the past week and talks with Cato were ongoing. The Lancashire side, who were promoted to League One in 2021, were relegated from League Two last season - their second relegation in the past three seasons.
Forbes
24 minutes ago
- Forbes
How Fixed Wireless Access Is Rewriting The Rules For Broadband
Eric Updyke, CEO at Spirent Communications. Did the telecom industry overlook one of the biggest opportunities in 5G? Judging from media buzz, you might think so. Early discussions were dominated by futuristic use cases—network slicing, ultra-low latency and millimeter wave—many of which were still years from deployment. Meanwhile, a quieter revolution was brewing. Many operators were making a strategic bet on something far more immediate and practical: fixed wireless access (FWA). That bet is paying off. FWA has rapidly emerged as one of the most successful use cases for 5G to date. According to the Global mobile Suppliers Association (GSA), there are now more than 200 commercial 5G FWA deployments and growing. In North America, T-Mobile and Verizon have already surpassed their 2025 targets for FWA customers, with T-Mobile now expecting 12 million connections by 2028 and Verizon anticipating 8-9 million in the same timeframe. Ericsson predicts that by 2029, there will be 330 million FWA connections worldwide, generating approximately $75 billion in revenue. How did 5G FWA seemingly come out of nowhere to become this burgeoning industry phenomenon? Let's take a closer look. Fueling Competition On one level, it's not surprising that 5G FWA didn't capture early headlines. After all, it's just internet connectivity, right? Haven't we had broadband for decades? Well, yes and no. If you live in a rural region or developing market—or even if you'd just like more competition on pricing and performance—having a brand-new internet option can be quite compelling. Especially one that delivers performance on par with fiber without the need for last-mile cabling. Suddenly, some of the biggest longstanding broadband challenges—bridging the digital divide, connecting remote locations, spurring investment in developing markets—become far less challenging. Even operators have been surprised by market enthusiasm for FWA. Whether targeting urban cable subscribers or bringing cost-effective broadband to new regions, they're finding customers hungry for new choices. Operators are finding FWA to be an effective lever for the following: In regions where fiber buildouts are cost-prohibitive, FWA enables mobile operators to offer home broadband wherever they have 5G coverage. In many cases, performance has been found to rival traditional wired connections. Our research found that 2024 monthly revenue per user for 5G FWA averaged approximately $46 in the United States, $35 in Western Europe and $70 in the Middle East. And that's just the starting point. Providers are finding a strong appetite for upsell services—like speed boosts, smart home bundles and integrated home-and-mobile packages. FWA offers a lower-cost, faster path to market entry. Operators can assess uptake in a region to inform future fiber expansion plans, using FWA as both a service and a market testing tool. FWA's appeal extends beyond residential customers. At least 20 operators are now actively marketing FWA for business use, particularly targeting small and midsize enterprises in underserved areas. These offerings often come with SLAs and value-added services—like cybersecurity, unified communications and even AI edge hosting—creating a robust connectivity platform tailored for modern business needs. Assuring Quality With FWA adoption surging, attention is now turning to retention, differentiation and customer experience. And in broadband, that means one thing: quality. Speed matters, but it's not enough. End users care about performance for the applications they use every day—streaming, gaming, video calls and more. The FWA environment introduces unique challenges, including: • Airspace contention between FWA and mobile devices on shared spectrum • Interference between 5G signals and in-home Wi-Fi • Traffic imbalances within households, where one heavy user can degrade QoE for others These challenges can't be solved with a one-time fix. They require a comprehensive, lifecycle approach to testing—starting from design and continuing through deployment and operations. Effective strategies include: • Emulation And Simulation: Using digital twins to test networks and services in the lab, uncovering performance issues before live deployment. • Continuous Testing And Automation: Integrating functional and performance testing into CI/CD pipelines, enabling rapid, reliable deployment at scale. • Active Testing In Live Environments: Injecting synthetic test traffic to monitor SLA adherence and flag issues before they impact real users. Make no mistake—FWA introduces a new level of complexity compared to traditional broadband. But it also offers enormous opportunity. As adoption accelerates, operators who recognize this complexity and prioritize service quality will be best positioned to lead. The Most Disruptive Broadband Technology In Years Fixed wireless access is reshaping the broadband market faster than anyone predicted. It's opening doors for operators to expand footprints, compete more effectively and deliver meaningful value to customers—quickly and cost-efficiently. We may not have talked about it much during the early hype cycles of 5G, but FWA is rewriting the rules. It's not just a stopgap or rural solution—it's a transformative force in telecom. And its story is just beginning. Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?
Yahoo
an hour ago
- Yahoo
Do Wall Street Analysts Like Paramount Global Stock?
New York-based Paramount Global (PARA) is a leading media, streaming, and entertainment company offering television, film production, and digital content across various global platforms. With a market cap of $8.8 billion, the company owns a diverse portfolio of entertainment brands and provides streaming services, including Paramount+, Pluto TV, BET+, and Noggin. Shares of this entertainment giant have underperformed the broader market over the past year. PARA has gained 16.5% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 17.1%. However, in 2025, PARA stock is up 24.7%, surpassing the SPX's 8.6% fall on a YTD basis. More News from Barchart Tesla Just Signed a Chip Supply Deal with Samsung. What Does That Mean for TSLA Stock? Dear Microsoft Stock Fans, Mark Your Calendars for Aug. 1 Is Lucid Motors Stock a Buy, Sell, or Hold for July 2025? Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! Similarly, PARA has trailed the Communication Services Select Sector SPDR ETF (XLC), which has gained about 27.9% over the past year. However, PARA's double-digit returns on a YTD basis outshine the ETF's 10.6% rally over the same time frame. Paramount shares rose over 1% in pre-market trading on July 25, after receiving Federal Communications Commission's (FCC) approval for the company's merger with Skydance Media. This approval marks a significant step forward in the proposed deal, which aims to combine Paramount's extensive content library and global distribution network with Skydance's innovative production capabilities and strong track record in film and television. For fiscal 2025, ending in December, analysts expect PARA's EPS to decline 15.6% year over year to $1.30 on a diluted basis. The company's earnings surprise history is mixed. It beat the consensus estimate in three of the last four quarters, while missing the forecast on another occasion. Among the 23 analysts covering PARA stock, the consensus is a 'Moderate Sell.' That's based on two 'Strong Buy' ratings, 11 'Holds,' and 10 'Strong Sells.' This configuration is more bearish than three months ago, with three analysts suggesting a 'Strong Buy.' On Jul. 28, Seaport Global Securities downgraded Paramount Global from 'Neutral' to 'Sell,' setting a price target of $11 ahead of its August 7 merger with Skydance. The firm cautions that PARA shares may give back recent merger-driven gains after the deal closes. The company will begin trading under the new ticker PSKY post-merger. While PARA currently trades above its average mean price target of $11.67, its Street-high price target of $16 suggests an ambitious upside potential of 22.7%. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
